Dendritic cell-derived exosomes (Anosys)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameDendritic cell-derived exosomes (Anosys)
Drug Alias NameAutologous dendritic cell-derived exosomes (Anosys)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute Gustave-Roussy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnosys
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A